Prolonged electroconvulsive therapy seizure in a patient taking ciprofloxacin

Journal of ECT

Volumn 21, Issue 1, 2005, Pages 43-44

  Kisa, Cebrail ^a   Yildirim, Sema G ^a   Aydemir, Cigdem ^a,b   Cebeci, Sevsen ^a   Goka, Erol ^a  

^a Ankara Humune Hospital   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Ciprofloxacin; Depression; Electroconvulsive therapy; Seizure

Indexed keywords

CIPROFLOXACIN; MIDAZOLAM; PSYCHOTROPIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; EPILEPSY; FEMALE; HUMAN; MENTAL DISEASE; PUERPERAL DEPRESSION; SEIZURE; URINARY TRACT INFECTION;

ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DEPRESSION, POSTPARTUM; ELECTROCONVULSIVE THERAPY; EPILEPSY; FEMALE; HUMANS; URINARY TRACT INFECTIONS;

EID: 16344372655     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200503000-00012     Document Type: Article

References (16)

1. McCleave KJ, Blakemore WB. Anaesthesia for electroconvulsive therapy. Anaesth Intensive Care. 1975;3:250-256.
2. Klapheke MM. Combining ECT and antipsychotic agents: Benefits and risk. Convuls Ther. 1993;9:241-255.
3. Rosenbach ML, Hermann RC. Use of ECT in the medicine population between 1987 and 1992. Psychiatr Serv. 1997;48:1537-1542.
4. Yoshihisa I, Kumiko I. Characterization of quinolone antibacterial- induced convulsions and increases in nuclear AP-1 DNA and CRE-binding activities in mouse brain. Neuropharmacology. 1999;38:717-723.
5. Kushner JM, Peckman HJ, Snyder CR. Seizures associated with fluoroquinolones. Ann Pharmacother. 2001;35:1194-1198.
6. O'Donnell JA, Gelone SP. Fluoroquinolones. Infect Dis Clin North Am. 2000;14:489-513.
7. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother. 1990;26(Suppl):219-225.
8. Akahane K, Sekiquichi M, Une T, et al. Structure epileptogeniciry relationship of quinolones with special reference to their interaction with aminobutyric acid receptor sites. Antimicrob Agents Chemother. 1989;33:1704-1708.
9. Yamamoto K, Naitoh Y, Inoue Y, et al. Seizure discharges induced by the combination of a new quinolicarboxlic acid antimicrobial drugs and nonsteroidal antiinflamatory drugs. Chemotherapy. 1988;36(suppl):300-324.
10. Christ W, Gindler K, Gruene S, et al. Convulsions in mice treated with different quinolones in combination with fenbufen, a nonsteroidal antiinflamatory drug. Naunyn Schmiedebergs Arch Pharmacol. 1988; (337 suppl):114.
11. Niki Y, Hashiguchi K, Okimoto N, et al. Quinolone antimicrobial agents and teophylline. Chest. 1992;101:881.
12. Schwartz MT, Calvert JF. Potential neurologic toxicity related to ciprofloxacin. Ann Pharmacother. 1990;24:138-139.
13. Devita MV, Michelis MF. Perturbations in sodioum balance. Clin Lab Med. 1993;13:135-148.
14. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. Washington, DC: American Psychiatric Press; 2001.
15. Scott AI, McCreadie RG. Prolonged seizures detectable by electroencephalogram in electroconvulsive therapy. Br J Psychiatry. 1999;175:91-92.
16. Martin SJ, Meyer JM, Chuck SK, et al. Levofloxacin and sparfloxacin: new quinolone antibiotics. Ann Pharmacother. 1998;32:320-336.